N95 Masks Market Forecast, Trend Analysis & Competition Tracking - Global Industry Insights 2015 to 2031

Demand for N95 Masks from 2015 to 2020 Vs Future Market Projections for 2021-2031

From 2015 to 2020, sales of N95 Masks were high, expanding at under 4.1% CAGR.

With the sudden outbreak of COVID-19 in China's Wuhan province on 11 March 2020, the World Health Organization (WHO) declared the Novel Coronavirus Disease (COVID-19) outbreak as a pandemic ramped up the demand and sales of N95 Masks.

N95 respirators and surgical masks are essential parts of personal protective equipment used to protect the wearer from numerous airborne particles. The rising demand from frontline healthcare workers and the general population for N95 Masks is expected to grow the target market. The Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH), and the Occupational Safety and Health Administration (OSHA) also recommend the usage of N95 marks during this pandemic situation.

Global N95 Masks Market Revenue Outlook:

The global N95 masks market was valued at US$ 3.5 Bn in 2020 and is projected to register а САGR of 6.0% by 2031.

Nonetheless, various industry players in the global N95 masks market are now increasing their focus towards the establishment of successful collaborations, acquisitions, and joint venture activities as a means to enhance their respective customer bases. These players are also increasing their supply capabilities to meet customer requirements on a local and global scale. This factor, paired with promising industrialization prospects in developing economies of the Asia-Pacific region, such as China, India, Taiwan, Indonesia, etc., are expected to create massive business opportunities for key players over the forecast period.

How is demand for masks increasing N95 Masks sales?

An increasing number of cases caused by bacteria, viruses, fungi, or parasites, including Diphtheria, Ebola, Flu (Influenza), and others, has been noted recently. The growing prevalence of COVID-19 worldwide has increased the demand for N95 Masks designed to protect the mouth and nose from foreign biological infectious particles.

Some Major Funding for Coronavirus

The US funding for Coronavirus

The US has sanctioned an US$ 8.3 billion fund to fight the recent virus outbreak of COVID-19. This is a significantly huge amount compared to the funding budget allocated for other diseases, such as US$ 5.4 billion allocated for Ebola and US$ 7 billion for the H1N1 virus by the US health regulatory authority.

UK's funding for Coronavirus

Recently appointed UK Chancellor Rishi Sunak has made a US$ 35.49 billion budget to protect the country's economy from the adverse effects of the coronavirus pandemic. This budget aims to offer the most considerable boost to public investments for several generations to drive long-term growth.

Regional Development Mission for Asia

The Asian countries received a funding of US$ 800,000 for laboratory systems, case finding, surveillance, technical assistance, risk communications, prevent and control infection in health facilities

The World Bank Group is the largest donor of committed funds for COVID-19, announcing upwards of US$12 billion in immediate support for the country's response. Japan is the second-largest donor, devoting most of its US$1.6 billion in COVID-19 funding to the World Health Organization's COVID-19 response. The European Union and International Bank for Reconstruction and Development (IRBD) came together in third place with US$1.5 billion committed funds coming from each.

What Are The Key Challenges To Market Expansion For Manufacturers Of N95 Masks?

A significant challenge expected to hamper sales of N95 Masks is the rules and regulations differ from country to country, and the regulatory environment is ever-changing due to increasing development costs and times and market pressures impacting medical devices and the pharmaceutical sector. The differences in the regulations of different countries are driven by numerous economic, legal, or political factors, thus limiting market growth.

Low availability and sub-standard quality of non-medical facemasks in several countries for reducing the transmission and infectivity of COVID-2019 is expected to hamper the growth of the global N95 masks market. However, certain players are attempting to expand their business in overseas markets to expand their geographical footprint, widening expansion prospects.

How Supply Of N95 Masks is Affected In The Pandemic Situation?

COVID-19 pandemic has drastically affected most of the sector's growth. OEMs are trying to rapidly scale up production to stabilize the lost time and regain their lost market share during the lockdown. This is expected to provide lucrative opportunities for the market to grow at a remarkable rate in the forecast years.

Country-Wise Analysis

How Is The Growing Popularity Of N95 Masks Sales In The US?

The market for N95 Masks in the US is likely to expand at under 6.5% CAGR until 2031. This is owing to the increasing number of new COVID-19 cases, hospitalizations, and deaths in the US. According to the Centers for Disease Control and Prevention (CDC) figures, the average number of new US cases is about 11,000 a day. These factors have reinforced stick rules for wearing N95 masks in public places in the US and are expected to fuel the production of N95 Masks.

To learn more about this report, request for sample report

Why Is N95 Mask Significantly Used In The Healthcare Sector As Compared To Other End Users?

Numerous emerging and re-emerging infectious diseases such as Ebola, COVID -19 are a threat to public health all over the globe. Respiratory protective devices are useful in protecting against infection in healthcare, and are highly recommended in epidemiological situations. These masks include nurses, midwives, community health workers, doctors, and pharmacists using N95 masks in hospitals and are the backbone of effective health systems. Hence, the demand for N95 masks is continuously rising as the number of Covid–19 cases continue to increase daily.

Competitive Landscape

The N95 Masks landscape appears highly consolidated, with a significant chunk of it is dominated by US players.

• 3M
• Honeywell International, Inc.
• Prestige Ameritech
• Ansell Ltd.
• O&M Halyard
• The Gerson Company
• Cardinal Health
• Medline Industries, Inc.
• Kimberly-Clark Corporation
• Other Key Players

Some notable developments in the market include:

• In March 2021, Shawmut Corporation and Fallon Company's partnership launched a NIOSH-approved Protex N95 mask with the patent-pending Protex ADC all-day-comfort system for prolonged use.
• In January 2021, Razer Inc. - a Singapore–based company that designs, develops, and sells consumer electronics, financial services, and gaming hardware have launched a concept N95 mask with RGB and voice projection.
• In December 2020, India–based company Breathe Easy Labs launched made-in-India Karbon face masks with three-layered protection.
• In August 2020, Honeywell International Inc. announced to expand its production capacity of N95 masks up to 2 million disposable face masks monthly at its Fulgaon manufacturing facility in Pune, India. The masks will be supplied to frontline healthcare workers, emergency responders, and government organizations.

Report Scope

• Forecast Period: 2022-2031
• Actual Year: 2021
• Historical Data Available for: 2015-2020

Key Regions Covered

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Segments Covered

N95 Masks Market, By Type

• With Exhalation Valve
• Without Exhalation Valve

N95 Masks Market, By Distribution Channel

• Retail Pharmacy
• Hypermarket/Supermarket
• Hospitals / Clinics
• Online Stores

N95 Masks Market, By End Users

• Healthcare
• Construction
• Manufacturing
• Mining, Oil & Gas
• Other End Users

To learn more about this report, request for sample report